News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
212,847 Results
Type
Article (10979)
Company Profile (60)
Press Release (201808)
Multimedia
Podcasts (12)
Webinars (4)
Section
Business (64798)
Career Advice (511)
Deals (13076)
Drug Delivery (42)
Drug Development (26761)
Employer Resources (31)
FDA (5509)
Job Trends (5782)
News (109457)
Policy (8605)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Standard (3)
Academia (821)
Accelerated approval (14)
Adcomms (4)
Allergies (60)
Alliances (12570)
ALS (45)
Alzheimer's disease (551)
Antibody-drug conjugate (ADC) (104)
Approvals (5678)
Artificial intelligence (126)
Autoimmune disease (39)
Automation (12)
Bankruptcy (74)
Best Places to Work (4594)
BIOSECURE Act (10)
Biosimilars (49)
Biotechnology (34)
Bladder cancer (68)
Brain cancer (16)
Breast cancer (258)
Cancer (1762)
Cardiovascular disease (169)
Career advice (405)
Career pathing (6)
CAR-T (82)
CDC (13)
Cell therapy (203)
Cervical cancer (16)
Clinical research (24263)
Collaboration (432)
Company closure (1)
Compensation (263)
Complete response letters (15)
COVID-19 (937)
CRISPR (32)
C-suite (153)
Cystic fibrosis (90)
Data (2641)
Depression (59)
Diabetes (159)
Diagnostics (2265)
Digital health (6)
Diversity, equity & inclusion (10)
Drug discovery (51)
Drug pricing (61)
Drug shortages (4)
Duchenne muscular dystrophy (77)
Earnings (41437)
Editorial (17)
Employer branding (3)
Employer resources (31)
Events (28249)
Executive appointments (171)
FDA (6735)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (10)
Frontotemporal dementia (8)
Funding (449)
Gene editing (62)
Generative AI (7)
Gene therapy (204)
GLP-1 (343)
Government (1302)
Grass and pollen (6)
Guidances (318)
Healthcare (6722)
HIV (26)
Huntington's disease (13)
IgA nephropathy (35)
Immunology and inflammation (93)
Immuno-oncology (20)
Indications (32)
Infectious disease (1035)
Inflammatory bowel disease (62)
Inflation Reduction Act (7)
Influenza (43)
Intellectual property (50)
Interviews (52)
IPO (7273)
IRA (16)
Job creations (1346)
Job search strategy (363)
JPM (14)
Kidney cancer (10)
Labor market (37)
Layoffs (229)
Leadership (4)
Legal (1589)
Liver cancer (34)
Longevity (5)
Lung cancer (255)
Lymphoma (184)
Machine learning (9)
Management (13)
Manufacturing (249)
MASH (64)
Medical device (4416)
Medtech (4427)
Mergers & acquisitions (6173)
Metabolic disorders (415)
Multiple sclerosis (56)
NASH (10)
Neurodegenerative disease (99)
Neuropsychiatric disorders (33)
Neuroscience (999)
NextGen: Class of 2026 (2206)
Non-profit (2166)
Now hiring (19)
Obesity (173)
Opinion (79)
Ovarian cancer (45)
Pain (70)
Pancreatic cancer (70)
Parkinson's disease (103)
Partnered (9)
Patents (79)
Patient recruitment (142)
Peanut (22)
People (10550)
Pharmaceutical (17)
Pharmacy benefit managers (11)
Phase 1 (6292)
Phase 2 (10380)
Phase 3 (9316)
Pipeline (2617)
Policy (77)
Postmarket research (948)
Preclinical (2156)
Press Release (19)
Prostate cancer (80)
Psychedelics (14)
Radiopharmaceuticals (65)
Rare diseases (377)
Real estate (1929)
Recruiting (11)
Regulatory (7163)
Reports (13)
Research institute (902)
Resumes & cover letters (119)
Rett syndrome (6)
RNA editing (2)
RSV (34)
Schizophrenia (82)
Series A (55)
Series B (50)
Service/supplier (4)
Sickle cell disease (32)
Special edition (9)
Spinal muscular atrophy (65)
Sponsored (8)
Startups (888)
State (1)
Stomach cancer (3)
Supply chain (30)
Tariffs (37)
The Weekly (12)
Vaccines (365)
Venture capital (32)
Weight loss (114)
Women's health (27)
Worklife (3)
Date
Today (18)
Last 7 days (202)
Last 30 days (679)
Last 365 days (10837)
2026 (1045)
2025 (10871)
2024 (12039)
2023 (13527)
2022 (15874)
2021 (17305)
2020 (17666)
2019 (16840)
2018 (12864)
2017 (10886)
2016 (9731)
2015 (11621)
2014 (8001)
2013 (6221)
2012 (6659)
2011 (7032)
2010 (5996)
Location
Africa (234)
Alabama (28)
Alaska (2)
Arizona (87)
Arkansas (6)
Asia (12095)
Australia (1789)
California (3759)
Canada (1076)
China (417)
Colorado (182)
Connecticut (208)
Delaware (139)
Europe (31049)
Florida (568)
Georgia (112)
Hawaii (1)
Idaho (15)
Illinois (288)
India (30)
Indiana (173)
Iowa (5)
Japan (181)
Kansas (56)
Kentucky (17)
Louisiana (18)
Maine (33)
Maryland (406)
Massachusetts (2771)
Michigan (88)
Minnesota (160)
Mississippi (2)
Missouri (64)
Montana (8)
Nebraska (6)
Nevada (32)
New Hampshire (41)
New Jersey (1273)
New Mexico (6)
New York (1021)
North Carolina (460)
North Dakota (1)
Northern California (1933)
Ohio (97)
Oklahoma (4)
Oregon (13)
Pennsylvania (807)
Puerto Rico (7)
Rhode Island (8)
South America (384)
South Carolina (8)
Southern California (1447)
Tennessee (64)
Texas (564)
United States (13651)
Utah (92)
Vermont (1)
Virginia (100)
Washington D.C. (14)
Washington State (309)
West Virginia (2)
Wisconsin (37)
Wyoming (1)
212,847 Results for "50".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
BioRestorative Announces Pricing of $5.0 Million Public Offering
February 12, 2026
·
5 min read
Press Releases
National Organization for Rare Disorders Ranks All 50 States on Rare Disease Policies
February 10, 2026
·
4 min read
Press Releases
Helsinn announces new Executive Leadership Team as it celebrates 50 years
January 13, 2026
·
3 min read
Press Releases
University of Pennsylvania, BioNTech, and OUP Launch $50 Million Life Sciences Fund
January 12, 2026
·
6 min read
Press Releases
Foghorn Therapeutics Announces Closing of $50 Million Registered Direct Financing at a 30% Premium
January 14, 2026
·
2 min read
Earnings
J&J Targets $50B Oncology Sales By 2030: Updated
Johnson & Johnson’s $23.7 billion in second-quarter earnings, driven by cancer and neuroscience drugs, exceeded analyst expectations, while CEO Joaquin Duato set a target of $50 billion in oncology sales by 2030.
July 16, 2025
·
2 min read
·
Nick Paul Taylor
Press Releases
Immutep Achieves 50% Enrolment in Global TACTI-004 (KEYNOTE-F91) Phase III Trial in 1L NSCLC
February 8, 2026
·
4 min read
Press Releases
Spruce Biosciences Secures Up to $50 Million in Growth Capital from Avenue Capital
January 8, 2026
·
5 min read
Press Releases
TRexBio Closes $50 Million Financing to Support a Growing Clinical-Stage Immunology Pipeline of Tissue-Targeted Treg Therapeutics
January 27, 2026
·
4 min read
Press Releases
Morphocell Technologies Completes US$50 Million Series A Financing
December 2, 2025
·
4 min read
1 of 21,285
Next
